Center to Advance POC Diagnostics for Global Health
全球健康 POC 诊断推进中心
基本信息
- 批准号:7688789
- 负责人:
- 金额:$ 24.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-09-30 至 2012-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The use of appropriate point-of-care (POC) diagnostic tests can mean the difference between the right
treatment or continued sickness or death: In low-resource settings (LRS), especially in developing countries,
diagnostic capabilities are minimal, inadequate, or nonexistent. New and innovative POC diagnostic
technologies designed specifically for LRS will have a major impact on global public health by: providing
timely and appropriate patient treatment, reducing over-prescription of drugs, restraining the spread of drug
resistance and raising early alerts of a potential pandemic disease. Emerging technologies in diagnostics
offer the opportunity to address many of the clinical unmet needs in LRS.
PATH, an international leader in the development of affordable and appropriate diagnostic tests, and its
partners are proposing a Center to Advance Point-of-Care Diagnostics for Global Health (the Center). Over
the course of five years, the Center will accelerate the development and deployment of POC diagnostic tests
essential to LRS by: conducting laboratory- and field-based clinical evaluation of up to five selected
prototype POC diagnostic tests (Core 1); identifying and selecting up to four innovative and promising
technologies for potential development as POC diagnostic tests (Core 2); conducting assessments of the
critical clinical needs related to POC diagnostics in relevant resource-limited settings (Core 3); offering a
rigorous training program to educate technology developers and researchers, scientists, and engineers,
including those from private-sector companies, on the realities of providing health care in LRS (Core 4); and
lastly by coordinating activities through a strong, integrated management team and with the required
institutional support (technical, facilities, administrative, financial, legal, and logistical) (Core 5). Through
training and generation of manuals, tutorials, and standard operating procedures for the activities of all
cores, and rigorous plans for dissemination of needs assessment and research, the Center will have an
impact beyond its five-year duration.
Managed by PATH, with collaboration from the University of Washington (UW) Department of Global Health
as the lead on the training core, the Center will play a central role in accelerating the development and
introduction of diagnostic tests for use at the POC. PATH'S unique and extensive experience in working with
public- and private-sector partners at all stages of the product development, field testing, and introduction
process, together with the UW's experience in training in LRS, provide the ideal support for the project's
ultimate goal: to improve health among underserved populations worldwide by increasing the availability,
accessibility, and affordability of essential POC diagnostic tests.
使用适当的护理点(POC)诊断测试可能意味着右边的差异
治疗或持续的疾病或死亡:在低资源环境(LRS)中,尤其是在发展中国家,
诊断能力最少,不足或不存在。新的和创新的POC诊断
专门为LRS设计的技术将对全球公共卫生产生重大影响:提供
及时且适当的患者治疗,减少药物的过度处方,限制药物的扩散
抵抗和提高潜在大流行病的早期警报。诊断技术的新兴技术
提供机会解决LRS中许多临床未满足需求的机会。
Path,是经济实惠且适当的诊断测试发展的国际领导者及其
合作伙伴正在提出一个中心,以推进全球健康(中心)的护理点诊断。超过
五年的过程,该中心将加速POC诊断测试的开发和部署
对LRS的必不可少
原型POC诊断测试(CORE 1);识别和选择多达四个创新和有希望的
作为POC诊断测试的潜在发展技术(CORE 2);进行评估
相关资源有限设置中的POC诊断相关的关键临床需求(CORE 3);提供
严格的培训计划,以教育技术开发人员,研究人员,科学家和工程师,
包括来自私营部门公司的公司,关于在LRS提供医疗保健的现实(核心4);和
最后,通过一个强大的综合管理团队协调活动,并与所需的
机构支持(技术,设施,行政,财务,法律和后勤)(核心5)。通过
培训和生成所有活动的手册,教程和标准操作程序
核心以及严格的需求评估和研究计划,该中心将有一个
超出其五年的影响。
由Path管理,由华盛顿大学全球卫生系合作
作为训练核心的领导,该中心将在加速发展和
引入诊断测试以在POC中使用。 Path在与之合作的独特而丰富的经验
产品开发,现场测试和简介的所有阶段的公共和私营部门合作伙伴
流程,加上UW在LRS培训方面的经验,为项目提供了理想的支持
最终目标:通过增加可用性来改善全球服务不足的人群的健康状况,
可访问性和必需POC诊断测试的可负担性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Bernhard H. Weigl其他文献
Sample Acquisition and Control On-Chip Microfluidic Sample Preparation
- DOI:10.1016/s1535-5535(04)00089-910.1016/s1535-5535(04)00089-9
- 发表时间:2000-08-012000-08-01
- 期刊:
- 影响因子:
- 作者:Thomas Schulte;Ron Bardell;Bernhard H. WeiglThomas Schulte;Ron Bardell;Bernhard H. Weigl
- 通讯作者:Bernhard H. WeiglBernhard H. Weigl
共 1 条
- 1
Bernhard H. Weigl的其他基金
Center to Advance POC Diagnostics for Global Health
全球健康 POC 诊断推进中心
- 批准号:81076558107655
- 财政年份:2007
- 资助金额:$ 24.19万$ 24.19万
- 项目类别:
Center to Advance POC Diagnostics for Global Health
全球健康 POC 诊断推进中心
- 批准号:78867177886717
- 财政年份:2007
- 资助金额:$ 24.19万$ 24.19万
- 项目类别:
Center to Advance POC Diagnostics for Global Health
全球健康 POC 诊断推进中心
- 批准号:74997097499709
- 财政年份:2007
- 资助金额:$ 24.19万$ 24.19万
- 项目类别:
Center to Advance POC Diagnostics for Global Health
全球健康 POC 诊断推进中心
- 批准号:81811588181158
- 财政年份:2007
- 资助金额:$ 24.19万$ 24.19万
- 项目类别:
Center to Advance POC Diagnostics for Global Health
全球健康 POC 诊断推进中心
- 批准号:73419607341960
- 财政年份:2007
- 资助金额:$ 24.19万$ 24.19万
- 项目类别:
Center to Advance POC Diagnostics for Global Health
全球健康 POC 诊断推进中心
- 批准号:79081207908120
- 财政年份:2007
- 资助金额:$ 24.19万$ 24.19万
- 项目类别:
Center to Advance POC Diagnostics for Global Health
全球健康 POC 诊断推进中心
- 批准号:79426157942615
- 财政年份:2007
- 资助金额:$ 24.19万$ 24.19万
- 项目类别:
Center to Advance POC Diagnostics for Global Health
全球健康 POC 诊断推进中心
- 批准号:76438507643850
- 财政年份:2007
- 资助金额:$ 24.19万$ 24.19万
- 项目类别:
相似国自然基金
阿魏酸基天然抗氧化抗炎纳米药物用于急性肾损伤诊疗一体化研究
- 批准号:82302281
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于hemin-MOFs的急性心肌梗塞标志物负背景光电化学-比色双模分析
- 批准号:22304039
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
RNA甲基转移酶NSUN2介导SCD1 mRNA m5C修饰调控急性髓系白血病细胞铁死亡的机制研究
- 批准号:82300173
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于IRF5/MYD88信号通路调控巨噬细胞M1极化探讨针刀刺营治疗急性扁桃体炎的机制研究
- 批准号:82360957
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:地区科学基金项目
相似海外基金
Treatment Development for Smoking Cessation and Engagement in HIV/TB Care in South Africa
南非戒烟和参与艾滋病毒/结核病护理的治疗方法开发
- 批准号:1070687410706874
- 财政年份:2023
- 资助金额:$ 24.19万$ 24.19万
- 项目类别:
An mHealth implementation strategy to address the syndemic of mental illness, hypertension, and HIV in Uganda
解决乌干达精神疾病、高血压和艾滋病毒综合症的移动医疗实施战略
- 批准号:1075299210752992
- 财政年份:2023
- 资助金额:$ 24.19万$ 24.19万
- 项目类别:
Host cell membrane perforation during invasion by Toxoplasma gondii
弓形虫入侵过程中宿主细胞膜穿孔
- 批准号:1058765810587658
- 财政年份:2023
- 资助金额:$ 24.19万$ 24.19万
- 项目类别:
Universal Rapid test for HIV Diagnosis
HIV 诊断的通用快速检测
- 批准号:1076141510761415
- 财政年份:2023
- 资助金额:$ 24.19万$ 24.19万
- 项目类别:
m6A mRNA reader proteins in the AIDS-opportunistic pathogen Toxoplasma gondii
艾滋病机会致病菌弓形虫中的 m6A mRNA 阅读器蛋白
- 批准号:1061537410615374
- 财政年份:2023
- 资助金额:$ 24.19万$ 24.19万
- 项目类别: